IL10 and hemolytic-uremic syndrome: These results suggest that the presence of −1082G allele could contribute to an enhanced IL-10 response in HUS patients, which might derive from heightened promoter sensitivity to the inflammatory stimulus generated during the initial phase of HUS disease.